ZFGUD-TZ 281.25 Injection is a specialized pediatric broad-spectrum combination antibiotic formulation containing Ceftriaxone and Tazobactam (281.25 mg). It is designed for the effective treatment of severe bacterial infections in infants and children.
Key Features & Indications:
- Synergistic Antibacterial Action: Combines Ceftriaxone, a potent third-generation cephalosporin, with Tazobactam, a beta-lactamase inhibitor that prevents bacterial resistance and enhances antimicrobial activity.
- Pediatric Infection Management: Highly effective in managing lower respiratory tract infections, severe otitis media, urinary tract infections, skin infections, and systemic bacterial conditions in pediatric patients.
- Targeted Low-Dose Formulation: Precisely dosed at 281.25 mg to support safe, flexible, and accurate administration for infants and young children.
Dosage & Administration:
- Administration: FOR I.V./I.M. USE. Reconstitute with the provided 10 mL sterile water for injection and administer strictly under the supervision of a qualified pediatrician or medical professional.
- Storage: Store below 25°C in a cool, dry place protected from light and moisture. Keep out of reach of children.
